Skip to main content

Paradigm Biocapital Advisors LP

SEC CIK
0001855655
Latest filing
Aug 14, 2026

NUVL holding history

Nuvalent, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NUVL overviewAll 13F holders of NUVLFull Q2 2026 holdings

Shares (Q2 2026)
5,924,433
Value
$731.7M
% of portfolio
13.7%
Quarters held
13
Since Q2 2023
Holdings of NUVL by Paradigm Biocapital Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,924,433$731.7M13.7%+600,000+11.3%AddedHolders
Q1 20265,324,433$545.5M11.1%+55,000+1.0%AddedHolders
Q4 20255,269,433$530.1M14.2%00.0%UnchangedHolders
Q3 20255,269,433$455.7M13.5%00.0%UnchangedHolders
Q2 20255,269,433$402.1M17.2%00.0%UnchangedHolders
Q1 20255,269,433$373.7M17.2%−93,946−1.8%ReducedHolders
Q4 20245,363,379$419.8M14.6%+363,379+7.3%AddedHolders
Q3 20245,000,000$511.5M17.9%+428,322+9.4%AddedHolders
Q2 20244,571,678$346.8M13.3%+393,848+9.4%AddedHolders
Q1 20244,177,830$313.7M11.0%+319,822+8.3%AddedHolders
Q4 20233,858,008$283.9M13.3%+2,219,861+135.5%AddedHolders
Q3 20231,638,147$75.3M5.1%+517,682+46.2%AddedHolders
Q2 20231,120,465$47.3M3.8%+1,120,465NewHolders